Practice Variation in Prescribing SGLT2-Inhibitors: A Population-Based Analysis from Alberta, Canada [0.03%]
Rahim Kanji,Derek S Chew,Flora Au et al.
Rahim Kanji et al.
Background: Sodium glucose-cotransporter 2 inhibitors (SGLT2is) have been shown to reduce the risk of cardiorenal complications in select patient populations, yet their real-world uptake in clinical practice is limited. T...
Association Between the Emergency Heart Failure Mortality Risk Grade (EHMRG30-ST) and Costs of Care [0.03%]
Karem Abdul-Samad,Shijie Zhou,Maria Santiago-Jimenez et al.
Karem Abdul-Samad et al.
Background: The Emergency Heart Failure Mortality Risk Grade (EHMRG30-ST) is a clinically validated model that predicts 30-day mortality in heart failure patients presenting to the emergency department (ED). However, the ...
Dana Krim,Raja Hatem,Samuel Larue-Grondin
Dana Krim
Hamood Al-Harbi,Sheldon M Singh
Hamood Al-Harbi
Barriers of Successful Implementation of Discharge Criteria at a Tertiary Heart Function Clinic: A Retrospective Cohort Analysis [0.03%]
Rami Idris,Ansh Patel,Dhruv Srikanth et al.
Rami Idris et al.
Background: Most heart function clinics cannot absorb their high volume of referrals. The effectiveness of clinic discharge protocols to offload stable patients is understudied. We examined predictors and barriers of impl...
Early Diastolic Release Flow Is a Sensitive Early Marker for Left Ventricular Apical Aneurysm in Patients with Hypertrophic Cardiomyopathy [0.03%]
Syed Bukhari,Ali Asghar Kassamali,Henry Pronovost et al.
Syed Bukhari et al.
Background: Left ventricular apical aneurysm (LVAA) is a rare but important finding in hypertrophic cardiomyopathy (HCM) that is associated with increased risk for ventricular arrhythmia and thromboembolism. Doppler evide...
Tropheryma whipplei Endocarditis Diagnosed by Tissue 16S rRNA Gene Sequencing: A Case Report [0.03%]
应用组织16S rRNA基因测序诊断Whipple菌心内膜炎的病例报告
Takashi Maeda,Shun Kohsaka,Nozomi Niimi et al.
Takashi Maeda et al.
Case Reports
CJC open. 2025 Oct 25;8(2):160-163. DOI:10.1016/j.cjco.2025.10.008 2025
Rescue Mitral Clip Therapy in Hypertrophic Obstructive Cardiomyopathy with Severe Mitral Regurgitation and Combined Shock [0.03%]
hypertrophic梗阻性心肌病重度二尖瓣反流合并心源性休克的救治——缘夹治疗一例
Ofir Rabi,Shemy Carasso,Yigal Helviz et al.
Ofir Rabi et al.
Case Reports
CJC open. 2025 Nov 1;8(2):127-130. DOI:10.1016/j.cjco.2025.10.015 2025
Follow-up Dosing of Guideline-Indicated Medications After Myocardial Infarction: Insights from the Acute Myocardial Infarction Quality Assurance (AMIQA) Canada Study [0.03%]
急性心肌梗死后的指南推荐药物应用情况：来自加拿大急性心肌梗死质量保证（AMIQA）研究的洞见
Oswald Chen,Todd A Wilson,Matthew T Bennett et al.
Oswald Chen et al.
Background: Achieving the target doses of indicated medications after myocardial infarction (MI) is associated with improved outcomes and is a marker of the quality of care. We studied the use and follow-up dosing of core...
Residual Mitral Regurgitation After Transcatheter Edge-to-Edge Repair Worsens Survival in Patients with Renal Dysfunction [0.03%]
经导管二尖瓣修复术后残余二尖瓣反流对肾功能不全患者的生存率的影响
Dennis Rottländer,Jörg Hausleiter,Thomas Schmitz et al.
Dennis Rottländer et al.
Background: Chronic kidney disease (CKD) and postprocedural acute kidney injury (AKI) are predictors of survival after mitral transcatheter edge-to-edge repair (TEER). This study aimed to assess the impact of residual mit...